Author:
Powles Thomas,Necchi Andrea,Rosen Galit,Hariharan Subramanian,Apolo Andrea B.
Reference64 articles.
1. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Bladder cancer. v5. 2017.
2. Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer;Kaufman;J Clin Oncol,2000
3. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000
4. Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy;Apolo;J Natl Cancer Inst,2013
5. Nomogram-based prediction of overall survival in patients with metastatic urothelial carcinoma receiving first-line platinum-based chemotherapy: retrospective international study of invasive/advanced cancer of the urothelium (RISC);Necchi;Eur Urol,2017
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献